These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 24517570)

  • 21. Polymer-cysteamine conjugates: new mucoadhesive excipients for drug delivery?
    Kast CE; Bernkop-Schnürch A
    Int J Pharm; 2002 Mar; 234(1-2):91-9. PubMed ID: 11839440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biopharmaceutical Potential of Selegiline Loaded Chitosan Nanoparticles in the Management of Parkinson's Disease.
    Rukmangathen R; Yallamalli IM; Yalavarthi PR
    Curr Drug Discov Technol; 2019; 16(4):417-425. PubMed ID: 29669501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and characterisation of mucoadhesive thiolated polymers.
    Bernkop-Schnürch A; Steininger S
    Int J Pharm; 2000 Jan; 194(2):239-47. PubMed ID: 10692648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent advances in Parkinson's disease therapy: use of monoamine oxidase inhibitors.
    Henchcliffe C; Schumacher HC; Burgut FT
    Expert Rev Neurother; 2005 Nov; 5(6):811-21. PubMed ID: 16274338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain targeted delivery of mucoadhesive thermosensitive nasal gel of selegiline hydrochloride for treatment of Parkinson's disease.
    Sridhar V; Wairkar S; Gaud R; Bajaj A; Meshram P
    J Drug Target; 2018 Feb; 26(2):150-161. PubMed ID: 28682134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of buccal drug delivery systems based on a thiolated polymer.
    Langoth N; Kalbe J; Bernkop-Schnürch A
    Int J Pharm; 2003 Feb; 252(1-2):141-8. PubMed ID: 12550789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and in vivo evaluation of a patch system based on thiolated polymers.
    Hoyer H; Greindl M; Bernkop-Schnürch A
    J Pharm Sci; 2009 Feb; 98(2):620-7. PubMed ID: 18661531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The pharmacokinetic evaluation of selegiline ODT for the treatment of Parkinson's disease.
    Tábi T; Szökő E; Vécsei L; Magyar K
    Expert Opin Drug Metab Toxicol; 2013 May; 9(5):629-36. PubMed ID: 23506388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and in vivo evaluation of buccal tablets prepared using danazol-sulfobutylether 7 beta-cyclodextrin (SBE 7) complexes.
    Jain AC; Aungst BJ; Adeyeye MC
    J Pharm Sci; 2002 Jul; 91(7):1659-68. PubMed ID: 12115827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of thiolated alginate and evaluation of mucoadhesiveness, cytotoxicity and release retardant properties.
    Jindal AB; Wasnik MN; Nair HA
    Indian J Pharm Sci; 2010 Nov; 72(6):766-74. PubMed ID: 21969750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioequivalence evaluation of two preparations containing the highly variable compound selegiline (L-deprenyl).
    Waitzinger J; Ludwig G; Pabst G; Michaelis K; Reh C
    Int J Clin Pharmacol Ther; 1996 Oct; 34(10):427-32. PubMed ID: 8897080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selegiline orally disintegrating tablets for the treatment of Parkinson's disease.
    Lew MF
    Expert Rev Neurother; 2005 Nov; 5(6):705-12. PubMed ID: 16274328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved Mucoadhesion, Permeation and In Vitro Anticancer Potential of Synthesized Thiolated Acacia and Karaya Gum Combination: A Systematic Study.
    Munot N; Kandekar U; Rikame C; Patil A; Sengupta P; Urooj S; Bilal A
    Molecules; 2022 Oct; 27(20):. PubMed ID: 36296425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of improved buccal permeation and bioavailability of felodipine microemulsion-based cross-linked polycarbophil gel.
    Singh M; Kanoujia J; Parashar P; Arya M; Tripathi CB; Sinha VR; Saraf SK; Saraf SA
    Drug Deliv Transl Res; 2018 Jun; 8(3):591-601. PubMed ID: 29423833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic evaluation of a selegiline pulsatile oral delivery system.
    Rohatagi S; Barrett JS; DeWitt KE; Lessard D; Morales RJ
    Biopharm Drug Dispos; 1997 Nov; 18(8):665-80. PubMed ID: 9373724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioavailability of two selegiline hydrochloride tablet products.
    Müller FO; Schall R; Hundt HK; Joubert A; Middle MV; Muir AR; Duursema L; Groenewoud G; Swart KJ
    Arzneimittelforschung; 1996 Nov; 46(11):1037-40. PubMed ID: 8955861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Provesicular granisetron hydrochloride buccal formulations: in vitro evaluation and preliminary investigation of in vivo performance.
    Ahmed S; El-Setouhy DA; El-Latif Badawi AA; El-Nabarawi MA
    Eur J Pharm Sci; 2014 Aug; 60():10-23. PubMed ID: 24793896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nasal delivery of antisense oligonucleotides: in vitro evaluation of a thiomer/glutathione microparticulate delivery system.
    Vetter A; Bernkop-Schnürch A
    J Drug Target; 2010 May; 18(4):303-12. PubMed ID: 19947818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Propranolol Hydrochloride Buccoadhesive Tablet: Development and
    Mortazavi SM; Mortazavi SA
    Iran J Pharm Res; 2020; 19(2):22-33. PubMed ID: 33224208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymers with thiol groups: a new generation of mucoadhesive polymers?
    Bernkop-Schnürch A; Schwarz V; Steininger S
    Pharm Res; 1999 Jun; 16(6):876-81. PubMed ID: 10397608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.